Publications in collaboration with researchers from Université de Genève (1)

2022

  1. Re: Beckers et al.: Safety and effectiveness of the PRESERFLO® MicroShunt in primary open-angle glaucoma: results from a 2-year multicenter study. <i>Ophthalmol Glaucoma</i> (2021;doi 10.1016/j.ogla.2021.07. 008: Jul 28 [Epub ahead of print].) REPLY

    OPHTHALMOLOGY GLAUCOMA